VEKLURY subst sèche 100 mg flac
7680680260012
CH-68026
J05AB16
08.03.0.
Reimbursement limitations:
VEKLURY.01a
VEKLURY est remboursé en tant que monothérapie antivirale dans le traitement d’une infection COVID-19 confirmée …
1 / 3
google
Details
- Product number
- 6802601
- CPT
- -
- Packaging group
- 1
- Unit
- Durchstechflasche(n)
- Composition
- Praeparatio cryodesiccata: remdesivirum 100 mg, sulfobutylbetadexum natricum 3.146 g, acidum hydrochloridum, natrii hydroxidum, pro vitro corresp. natrium 211.8 mg.
Articles (1)
Veklury, Pulver für Konzentrat zur Herstellung einer Infusionslösung
Pulver
1
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
PRC
|
100.0 MG | Substance | Wirkstoff (Principe actif) |
|
PRC
|
3.146 G | Substance | HBESI |
|
PRC
|
- | Substance | HNIDK |
|
PRC
|
- | Substance | HNIDK |
|
PRC
|
211.8 MG | Substance | HBESI |
Reimbursement information
Public price
CHF 430.25
Specialties list
Yes
Generic
No
Reimbursement limitation
SL addition date:
01/09/2022
Authorization holder
Gilead Sciences Switzerland Sàrl
6300 Zug
Authorization information
- Swissmedic authorization number
- 68026
- Drug name
- Veklury, Pulver für ein Konzentrat zur Herstellung einer Infusionslösung
- Galenic form
- PULPI
- ATC Code
- J05AB16
- Authorization status
- Z
- Dispensation category
- A
- First authorization
- 25/11/2020
- Authorization expiration date
- 31/12/2027
- IT number
- 08.03.0.
- Domain
- Human medicine
Packaging details
- Description (FR)
- VEKLURY subst sèche 100 mg flac
- Description (DE)
- VEKLURY Trockensub 100 mg Durchstf
- Market launch
- 25/11/2020
- Narcotic (BTM)
- No